Revere FDA Approval Decisions™ ::
Revere's proprietary drug database offers an unmatched capability to track the drug pipeline of all U.S.- and Canadian-listed biotech or pharmaceutical companies (including US ADRs), resulting in original, insightful, unbiased, and actionable monthly reports.
The Revere FDA Approval Decisions Report is a comprehensive calendar of FDA decisions for New Drug Application (NDA) and Biologic License Application (BLA) fillings. There are two components to each report: a review of FDA decisions for the past month and a look ahead to the following three months, including a breakdown of applications by sector, illness/condition and financial information on the companies involved.
Sample individual reports:
- FDA Approval Decisions Report for Nov, 2006 - PDF - View Report »
Individual Revere FDA Approval Decisions Reports are available for purchase in our e-commerce store at www.reveredata.com/reports/store . Access to Revere Reports also comes bundled with our flagship Revere Research™ software.